ST2 as checkpoint target for colorectal cancer immunotherapy
Kevin Van der Jeught(Laboratory of Molecular Genetics), Xiongbin Lu(Indiana University Health)
Cited by 52
Related Papers
Drug resistance and new therapies in colorectal cancer
|World Journal of Gastroenterology|2018|604
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
|Genes & Development|2005|383
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
|Advanced Science|2023|55